Johnson & Johnson to Acquire Atraverse Medical to Bolster Cardiac Device Portfolio

Published: 2026-04-24 09:28:21 ET JNJ

Published on 04/24/2026 at 09:28 am EDT - Modified on 04/24/2026 at 09:29 am EDT

By Connor Hart

Johnson & Johnson said Friday it agreed to acquire Atraverse Medical, aiming to strengthen its portfolio of cardiac ablation technologies.

Terms of the deal weren't disclosed. The transaction is expected to close in the second quarter.

Johnson & Johnson has been racing to catch up to competitors in the fast-growing market for devices that treat irregular heart rhythms, while also seeking to generally revive its broader medical-device business. The company last year temporarily halted U.S. sales of its Varipulse heart-rhythm device after reports of neurovascular events in patients, The Wall Street Journal reported.

Atraverse, a privately held medical-device company, develops next-generation left-heart access and radiofrequency technologies. Its products include the FDA-cleared Hotwire Transseptal Access System, a guidewire and generator system used in nearly 3,000 clinical procedures, J&J said.

Write to Connor Hart at [email protected]

(END) Dow Jones Newswires

04-24-26 0927ET